Leadership Team

Immunotec's leadership team is the heartbeat of the company. With extensive successful careers in direct selling and company development, our leaders are poised to take Immunotec to even greater heights of success.

• James A. Northrop

  President and CEO

  Jim Northrop has joined Immunotec with a strong background in leading companies to achieve significant growth. He is passionate about the products and business opportunity at Immunotec. His approach is to work closely with the Field and Home Office teams to develop the Immunotec business through organic growth of our customer base and Consultant network.

• Daniel Murphy

  Executive Vice-President and Chief Operating Officer

  With over 25 years of experience, Daniel Murphy’s expertise in enhancing corporate operations for maximum potential are well founded. He has a solid background in finance and operations within a variety of business models, specifically the direct selling industry. His experience includes Vice-President, Finances at Princess House where he met exciting challenges and objectives. His main objective at Immunotec is to increase the company’s overall value by strategically increasing revenue within the Canadian and U.S. markets. He is also Treasurer for both the Direct Selling Association of America and the Direct Selling Education Foundation.

• Patrick Montpetit

  Vice-President and Chief Financial Officer

  Patrick Montpetit has over 15 years of experience in senior financial management positions. He is a chartered accountant, specializing in corporate finance and has extensive experience in the life sciences and biopharmaceutical industries. Prior to joining Immunotec, Mr. Montpetit served as Vice-President, Finance and Chief Financial Officer of Bioniche Life Sciences Inc. and Director of Finance, Administration, Commercial Agreements and Alliances with DSM Biologics Inc. His professional repertoire includes having served as Chairman of the Quebec Biotechnology Association and Director of the Montreal InVivo organization. His extensive international and public company expertise plays an integral part in Immunotec’s local and international expansion objectives.

Top of Page

• Dr. Wulf Dröge, Ph.D.

  Senior Vice-President, Research & Development

  Dr. Dröge is a world-renowned scientist with more than forty years in basic and clinical research and more than 280 publications. After postdoctoral fellowships at the Max Planck Institute and Harvard University, Dr. Dröge has spent 3 years as a scientific member at the renowned Basel Institute of Immunology and 29 years as professor of cell biology at the University of Heidelberg and head of a department at the National Cancer Research Center of Germany (Deutsches Krebsforschungszentrum). He continues to write scientific articles and gives lectures at McGill University.

Top of Page